Harmony Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
9,641
-45
-0.5% -$46K 3.11% 6
2026
Q1
$8.91M Buy
9,686
+25
+0.3% +$25.3K 2.72% 7
2025
Q4
$10.4M Buy
9,661
+59
+0.6% +$56.4K 3.48% 6
2025
Q3
$7.33M Buy
9,602
+103
+1% +$76.6K 2.52% 6
2025
Q2
$7.4M Buy
9,499
+439
+5% +$341K 2.77% 6
2025
Q1
$7.48M Buy
9,060
+2,254
+33% +$1.88M 3.14% 6
2024
Q4
$5.25M Buy
6,806
+1,033
+18% +$855K 2.08% 9
2024
Q3
$5.11M Buy
5,773
+178
+3% +$160K 1.88% 11
2024
Q2
$5.07M Buy
5,595
+203
+4% +$162K 2.12% 9
2024
Q1
$4.2M Buy
5,392
+698
+15% +$497K 1.73% 13
2023
Q4
$2.74M Buy
+4,694
New +$2.74M 1.16% 26

Other funds holding LLY

Harmony Asset Management's LLY Position: Q2 2026 in Review

Harmony Asset Management reduced its Eli Lilly (LLY) stake by 0.46% in Q2 2026, selling an estimated $46K and leaving 9,641 shares worth $11.6M. The position accounts for 3.11% of the portfolio, ranked #6.

Harmony Asset Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harmony Asset Management held 9,641 shares of Eli Lilly worth $11.6M as of Q2 2026.
  • Harmony Asset Management sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 3.11% of Harmony Asset Management's portfolio in Q2 2026, its #6 holding.
  • Harmony Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.